Peter Vavagiakis
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
- Antifungal resistance and susceptibility
Papers in
-
- Antimicrobial Resistance in Staphylococcus 14
- Clostridium difficile and Clostridium perfringens research 4
- Infection Control in Healthcare 2
- Antifungal resistance and susceptibility 2
- Co-authors
- Maureen Miller (12 shared papers)Franklin D. Lowy (11 shared papers)Christian Cespedes (7 shared papers)Robert S. Klein (5 shared papers)Glenny Vasquez (3 shared papers)Qiuhu Shi (5 shared papers)Justin Knox (4 shared papers)Anne‐Catrin Uhlemann (3 shared papers)
- Journals
- Clinical Infectious Diseases (3 papers)PLoS ONE (3 papers)American Journal of Public Health (2 papers)Epidemiology and Infection (1 paper)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Peter Vavagiakis
18 papers receiving 683 citations
Peers
Comparison fields: 5 of 92
- Clinical Biochemistry 218
- Infectious Diseases 510
- Applied Microbiology and Biotechnology 20
- Epidemiology 213
- Molecular Medicine 21
Countries citing papers authored by Peter Vavagiakis
This map shows the geographic impact of Peter Vavagiakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vavagiakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vavagiakis more than expected).
Fields of papers citing papers by Peter Vavagiakis
This network shows the impact of papers produced by Peter Vavagiakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vavagiakis. The network helps show where Peter Vavagiakis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Vavagiakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 108 | |
| 2 | 2011 | 77 | |
| 3 | 2009 | 68 | |
| 4 | 2002 | 58 | |
| 5 | 1995 | 56 | |
| 6 | 2012 | 46 | |
| 7 | 2003 | 41 | |
| 8 | A national survey of alcohol screening and referral in college health centers. | 2004 | 36 |
| 9 | 2002 | 35 | |
| 10 | 2005 | 33 | |
| 11 | 2007 | 31 | |
| 12 | 2019 | 31 | |
| 13 | 2005 | 22 | |
| 14 | 2011 | 19 | |
| 15 | 2016 | 18 | |
| 16 | 2010 | 15 | |
| 17 | 2014 | 10 | |
| 18 | 2018 | 5 |
About Peter Vavagiakis
Peter Vavagiakis is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Clinical Biochemistry and Molecular Biology, having authored 18 papers that have together received 709 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (14 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Drug-Induced Adverse Reactions (3 papers), Infection Control in Healthcare (2 papers), Bacterial biofilms and quorum sensing (2 papers), Antifungal resistance and susceptibility (2 papers) and Syphilis Diagnosis and Treatment (2 papers). The work is most often cited by research in Clinical Biochemistry (218 citations), Infectious Diseases (510 citations), Applied Microbiology and Biotechnology (20 citations), Epidemiology (213 citations) and Molecular Medicine (21 citations). Peter Vavagiakis has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Maureen Miller, Franklin D. Lowy, Christian Cespedes, Robert S. Klein, Glenny Vasquez, Qiuhu Shi, Justin Knox, Anne‐Catrin Uhlemann, Rachel Gordon and Cory Hafer. Their work appears in journals such as Clinical Infectious Diseases, PLoS ONE, American Journal of Public Health, Epidemiology and Infection and JAIDS Journal of Acquired Immune Deficiency Syndromes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.